Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



Systemic steroid treatment of rarely seen genitourinary system manifestation in children with Henoch Schönlein purpura: Case report and literature analysis

Ayca Pinar Nas, Yasemin Men Atmaca, Oksan Derinoz Guleryuz.




Abstract
Cited by 0 Articles

Henoch-Schönlein Purpura (HSP) is the most commonly seen systemic leukocytoclastic vasculitis in children. Although it frequently presents with skin, joint, and gastrointestinal system involvement, genitourinary system involvement is rarely seen as well. We present a child with HSP-associated penile and scrotum involvement and a literature review was performed. An eight-years-old male patient who underwent five days systemic, five days oral steroid therapy in hospital and had a total recovery from the HSP-associated penile and scrotum involvement that is rarely reported in the literature. Scrotum and penile involvement are rare in patients with HSP; acceptable with a good prognosis. Disease-related genitourinary system involvement may be associated with findings such as penis and scrotum involvement, balanitis, urethritis, hematoma in the bladder wall, epididymo-orchitis and priapism. In the literature, most commonly scrotal edema or only penile involvement is mentioned. However, treatment for HSP is controversial, steroid and analgesic treatment can be applied in patients with HSP and penile/scrotum involvement.

Key words: Balanitis; child; Henoch-Schönlein purpura; penile-scrotal involvement; treatment






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.